Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients

  • STATUS
    Recruiting
  • participants needed
    102
  • sponsor
    School of Health Sciences Geneva
Send
Updated on 16 February 2024
See if I qualify
cancer
advanced cancer

Summary

The main objective of the present study is to evaluate the effects of the Revie intervention on the self-esteem of patients diagnosed with an advanced cancer. A pragmatic, two-arm parallel-group, waitlist randomized controlled trial is conducted. The study takes place in the oncology department of the University Hospitals of Geneva at 3 outpatient units with 102 participants (51 per group).

Description

The main objective of the present study is to evaluate the effects of the Revie intervention on the self-esteem of patients diagnosed with an advanced cancer. The secondary objectives are to evaluate the effects of the Revie intervention on spiritual well-being, personal development, life satisfaction, and the perception of the interaction with the nurses. A pragmatic, two-arm parallel-group, waitlist randomized controlled trial (WLRCT) is conducted in which participants are randomized into (i) intervention, or (ii) waitlist control groups. The intervention group (IG) receive the Revie intervention early on and the control group (CG) the same intervention but later on (i.e., after eight weeks).This monocentric study takes place in the oncology department of the University Hospitals of Geneva (HUG) at two outpatient units. The required sample size is 102 participants (51 per group).

Details
Condition Advanced Cancer
Age 18years - 100years
Treatment Revie ⊕
Clinical Study IdentifierNCT04254926
SponsorSchool of Health Sciences Geneva
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Adults 18 years with and advanced cancer
whose general health status is adequate for participation in the study based on a clinical assessment by the nurse / doctor; and
who consent to participate in the study

Exclusion Criteria

documented cognitive impairment that compromises capacity for discernment
command of French is insufficient for reading, writing, or conversing
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cancer
advanced cancer

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.